Drawing based on the label description. No photo yet.
a30 pill
Pill with imprint a30 is red, oval, 14 mm and has been identified as Upadacitinib 30 mg. It is supplied by Abbvie Inc.
Upadacitinib 30 mg
- Imprint
- a30
- Strength
- 30 mg
- Color
- Red
- Shape
- Oval
- Size
- 14 mm
- Score
- No score line
- Form
- Tablet, extended release
- Manufacturer
- Abbvie Inc
- NDC
- 0074-2310, 0074-2310-30, 0074-2310-20
Is this your pill? Check every detail
- The imprint reads exactly a30, on the same sides.
- It is red, oval, 14 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Rinvoq.
Ingredients
Active: Upadacitinib
Inactive: Silicon Dioxide, Hypromellose, Unspecified, Ferric Oxide Red, Magnesium Stearate, Mannitol, Microcrystalline Cellulose, Polyvinyl Alcohol, Unspecified, Polyethylene Glycol, Unspecified, Talc, Tartaric Acid, Titanium Dioxide
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
BUMEX 2
Bumetanide 2 mg
Red, oval, 13 mm
- M V13 Valsartan 80 mg Red, oval, 13 mm
- 7 5 500 Ertugliflozin and Metformin Hydrochloride 7.5 mg / 500 mg Red, oval, 15 mm
- AP 682 Oxycodone and Acetaminophen 7.5 mg / 300 mg Red, oval, 14 mm Schedule II
- SG 344 Olmesartan Medoxomil and Hydrochlorothiazide 40 mg / 25 mg Red, oval, 15 mm
- A54 Methylphenidate Hydrochloride 54 mg Red, oval, 13 mm Schedule II
Other Upadacitinib pills
- a15 Upadacitinib 15 mg Purple, oval, 14 mm
- a45 Upadacitinib 45 mg Yellow, oval, 14 mm
- No picture yet DIN 02495155 Upadacitinib 15 mg Rinvoq, Tablet (extended-release), sold in Canada
- No picture yet DIN 02520893 Upadacitinib 30 mg Rinvoq, Tablet (extended-release), sold in Canada
- No picture yet DIN 02539721 Upadacitinib 45 mg Rinvoq, Tablet (extended-release), sold in Canada